Centennial Wealth Advisory’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Centennial Wealth Advisory's BMY Position: Q2 2026 in Review
Centennial Wealth Advisory increased its Bristol-Myers Squibb (BMY) stake by 0.8% in Q2 2026, buying an estimated $1.84K and bringing the position to 4,016 shares worth $231K. The position accounts for 0.05% of the portfolio, ranked #168.
Centennial Wealth Advisory first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $242K in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Centennial Wealth Advisory held 4,016 shares of Bristol-Myers Squibb worth $231K as of Q2 2026.
- Centennial Wealth Advisory bought 32 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.84K.
- Bristol-Myers Squibb made up 0.05% of Centennial Wealth Advisory's portfolio in Q2 2026, its #168 holding.
- Centennial Wealth Advisory first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- Centennial Wealth Advisory's Bristol-Myers Squibb position peaked at $242K in Q1 2026.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Centennial Wealth Advisory's 13F filing for Q2 2026, filed 13 Jul 2026.